© 2022 MJH Life Sciences and AJMC - Managed Care News, Research, and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
January 07, 2022
In this AJMC® roundtable discussion, oncology health care decision-making
experts consider factors that affect the use of cancer immunotherapies
(CITs) and discuss approaches for actualizing policies and procedures within
community oncology teams.